November 14, 2025
A curated collection of experts perspectives across Clinical Adoption, Regulation, Scientific Innovation, Patient Impact and Global Health. About the VHGS II – Expert Voices series The Virtual
March 2, 2026
ELEM Biotech is participating in MWC26 with three panels, taking place 2-5 March 2026 in
January 27, 2026
ELEM Biotech participated in EUCROF26, the 9th Annual Conference, which took place 1–3 February 2026 in Amsterdam, the
January 13, 2026
The proposed computational framework provides a powerful tool for investigating HFrEF progression and electromechanical dysfunction. By accurately replicating pressure-volume loop characteristics and
December 16, 2025
Cardiovascular diseases remain the leading cause of death worldwide, yet cardiology is entering a completely new era: personalized therapies, earlier diagnosis, and predictive tools that just a few
December 15, 2025
Insights from leading experts on international adoption of Virtual Human technologies and the transformation of large healthcare
December 8, 2025
These findings demonstrate that computational models capture variability in drug response across pathologies and sexes, offering a predictive framework for preclinical safety evaluations and
December 8, 2025
Insights from leading experts on excellence in scientific research and the technological foundations of virtual
December 1, 2025
Insights from leading experts on excellence in scientific research and the technological foundations of virtual
November 25, 2025
There is no excerpt because this is a protected
November 24, 2025
Insights from leading experts on regulation, ethics, and the responsible deployment of Virtual
November 21, 2025
ELEM Biotech is taking part in the ESC Digital & AI, taking place 21–22 November in Berlin,
November 17, 2025
Insights from leading experts on strategic leadership and real-world clinical adoption of Virtual